Prevention of erosive oesophagitis relapse with pantoprazole

@article{Richter2004PreventionOE,
  title={Prevention of erosive oesophagitis relapse with pantoprazole},
  author={J. Richter and P. Fraga and M. Mack and S. Sabesin and W. Bochenek},
  journal={Alimentary Pharmacology \& Therapeutics},
  year={2004},
  volume={20}
}
Aim : To compare the safety and efficacy of pantoprazole and ranitidine in maintaining erosive oesophagitis healing. 
A debate on the roles of antireflux surgery and long term acid suppression in the management of gastro-oesophageal reflux disease
TLDR
The advantages/inconvenience of both long term strategies—that is, drugs versus surgery—is discussed, with a focus on the advantages of the laparoscopic route. Expand
Lansoprazole for Long-Term Maintenance Therapy of Erosive Esophagitis: Double-Blind Comparison with Ranitidine
TLDR
Daily therapy with lansoprazole to prevent the relapse of EE is effective, well tolerated, and superior to ranitidine in the maintenance of healing and symptom relief. Expand
Long-term management of gastroesophageal re fl ux disease with pantoprazole
Correspondence: Theo Scholten Allgemeines Krankenhaus Hagen, Gruenstr. 35, 58095 Hagen, Germany Tel +49 2331 201 2246 Fax +49 2331 201 2309 Email scholten@akh-hagen.de Abstract: Gastroesophageal reflExpand
An update on the use of pantoprazole as a treatment for gastroesophageal reflux disease
TLDR
Pantoprazole has been shown to improve acid reflux-related symptoms, heal esophagitis, and improve health-related quality of life more effectively than histamine-2 receptor antagonists. Expand
Intravenous Pantoprazole as Initial Treatment in Patients With Gastroesophageal Reflux Disease and a History of Erosive Esophagitis: A Randomized Clinical Trial
TLDR
In conclusion, IV/oral pantoprazole were similarly effective in suppressing basal and pentagastrin-stimulated gastric acid secretion in GERD patients with a history of EE. Expand
Meta-analysis of the efficacy and safety of pantoprazole in the treatment and symptom relief of patients with gastroesophageal reflux disease – PAN-STAR
TLDR
Pantoprazole 40 mg was associated with complete relief of GERD-related symptoms in the majority of patients with ERD and NERD and was very well tolerated throughout the whole study. Expand
Long-term management of GERD in the elderly with pantoprazole
TLDR
Clinical practice suggests that a low dose maintenance of PPIs should be used in older patients with GERD, because pantoprazole is significantly effective both for acute and long-term treatment with excellent control of relapse and symptoms. Expand
Treatment of uncomplicated reflux disease.
TLDR
On-demand treatment with a PPI in patients with troublesome reflux symptoms and without alarming features empirical PPI therapy is another option for initial management, and therapy should be withdrawn after initial success. Expand
Short and long-term PPI treatment for GERD. Do we need more-potent anti-secretory drugs?
TLDR
The superiority of PPIs over other drugs (antacids, prokinetics and H(2)-receptor antagonists) has now been established beyond doubt, both for short- and long-term treatment, however, there are still some unmet therapeutic needs in GERD and patients with non-erosive reflux disease (NERD) are less responsive to PPIs than those with erosive esophagitis. Expand
Efficacy and Safety of Pantoprazole Delayed-release Granules for Oral Suspension in a Placebo-controlled Treatment-withdrawal Study in Infants 1–11 Months Old With Symptomatic GERD
TLDR
Pantoprazole significantly improved GERD symptom scores and was well tolerated in infants with gastroesophageal reflux disease, however, during the DB treatment phase, there were no significant differences noted between pantoprazoles and placebo in withdrawal rates due to lack of efficacy. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 20 REFERENCES
Maintenance therapy with pantoprazole 20 mg prevents relapse of reflux oesophagitis
: Proton pump inhibitors can be effective as maintenance therapy in reducing the relapse rate of reflux oesophagitis at a dose lower than that used for acute healing.
Treating the symptoms of gastro‐oesophageal reflux disease: a double‐blind comparison of omeprazole and cisapride
TLDR
There are no comparative data in this respect for acid pump inhibitors and prokinetic agents in relation to gastro‐oesophageal reflux disease, but the use of these agents in combination with each other to treat this disease is suggested to be beneficial. Expand
Oral pantoprazole for erosive esophagitis: a placebo-controlled, randomized clinical trial
TLDR
Results indicate that pantoprazole offers a new option for treatment of erosive esophagitis, and among the three doses studied, the 40-mg dose was the most effective. Expand
Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study.
TLDR
The higher healing rate for omeprazole was also accompanied by a significantly faster and more substantial improvement in reflux symptoms, and there were no adverse events or clinically significant changes in the laboratory values attributable to the trial medication. Expand
Efficacy of Lansoprazole in the Short- and Long-Term Treatment of Gastro-Oesophageal Reflux Disease
TLDR
An overview of clinical studies regarding the treatment of reflux oesophagitis with the newly developed proton pump inhibitor (PPI) lansoprazole, compared with other acid suppressant drugs showed that, with regard to healing rate and symptomatic relief, lansiprazole was superior to H2 receptor antagonists. Expand
Oral pantoprazole for erosive esophagitis: a placebo-controlled, randomized clinical trial
TLDR
The results indicate that pantoprazole offers a new option for treatment of erosive esophagitis, and among the three doses studied, the 40-mg dose was the most effective. Expand
Pantoprazole 20 mg is an effective maintenance therapy for patients with gastro‐oesophageal reflux disease
TLDR
Both the 20 mg and 40 mg doses of pantoprazole are safe and effective in maintaining patients with healed reflux oesophagitis in remission, and for the majority of patients, the 20mg dose provides adequate long‐term therapeutic efficacy at a minimal drug exposure and lower costs. Expand
Efficacy of Lansoprazole in the Short-and Long-Term Treatment of Gastro-Oesophageal Reflux Disease A Systematic Overview
The aim of this survey was to systematically overview clinical studies, published in the English literature, regarding the treatment of reflux oesophagi tis with the newly developed proton pumpExpand
Omeprazole 40 mg once a day is equally effective as lansoprazole 30 mg twice a day in symptom control of patients with gastro‐oesophageal reflux disease (GERD) who are resistant to conventional‐dose lansoprazole therapy—a prospective, randomized, multi‐centre study
TLDR
Comparative studies of omeprazole and lansoprazole are scarce and even scarcer are comparisons of higher doses, and few studies have compared clinical end‐points such as oesophageal healing and symptom control. Expand
Efficacy and tolerability of pantoprazole 40 mg versus 80 mg in patients with reflux oesophagitis.
TLDR
The 40 mg pantoprazole dosage is comparable to 80 mg in reflux oesophagitis, both in efficacy and tolerability. Expand
...
1
2
...